Funding

KaliVir Immunotherapeutics

United States · Biotech · Healthtech

Develops oncolytic immunotherapies for patients with advanced solid tumors

Visit kalivir.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series A$14MCompany K Partners — Role not disclosedFlexus Partners — Role not disclosedNextrans — Role not disclosedQuad Investment Management — Role not disclosedSV Investment — Role not disclosed

Investors

Company K PartnersSeries AFlexus PartnersSeries ANextransSeries AQuad Investment ManagementSeries ASV InvestmentSeries A

Coverage

Aug 19, 2026KaliVir Immunotherapeutics · Series A

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Sourceskalivir.com ↗